News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 325–360
- Matches
- 22940
- Sources here
- 23
- Companies here
- 33
Active search
22940 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos
Shares of Ultragenyx Pharmaceutical RARE are rising in premarket trading today following the FDA's accelerated approval of DTX-401, an AAV8 gene therapy for glycogen storage disease type Ia (GSDIa). The therapy will be marketed in the United States as Genglycos (pariglasgene brecaparvovec-opnr) and is …
NetEase Inc Stock (NTES) Moved Down by 5.10% on Aug 20: Drivers Behind the Movement
NetEase Inc. (NTES) stock fell by 5.10% due to its Q2 financial results, which showed solid revenue but a significant miss on adjusted earnings per share. Increased marketing and operational expenses for global expansion negatively impacted operating margins and investor sentiment, despite strong performance …
Seagate Technology Holdings PLC Stock (STX) Moved Up by 3.05% on Aug 20: Key Drivers Unveiled
Seagate Technology Holdings PLC (STX) stock increased by 3.05% on August 20th, driven by institutional dip-buying and strong demand from the AI infrastructure buildout. The company's HAMR platform adoption, expanded pricing power, and recent financial results exceeding Wall Street estimates contributed to the positive …
NetEase Q2 2026 slides: revenue growth amid profit pressures
NetEase Inc. reported mixed results for Q2 2026, with revenue of $4.4 billion surpassing analyst expectations but earnings falling short, leading to a 4.69% stock decline. Despite strong top-line growth driven by its gaming segment and expanded gross profit margins, the company's net income …
Cosmos Health signs exclusive Saudi distribution deal for supplements
Cosmos Health Inc. has secured an exclusive distribution agreement with Innova Healthcare for its Sky Premium Life food supplements in Saudi Arabia. The five-year deal, renewable for another five, includes an initial purchase order of 126,000 units and anticipates over 5 million units in …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Americold Realty Trust, Inc. - COLD
Pomerantz LLP is investigating Americold Realty Trust, Inc. (NYSE: COLD) following a significant drop in its stock price. This investigation comes after Americold announced a non-cash impairment charge of approximately $305 million to $320 million due to the termination of agreements with ADUSA Distribution, …
AMTD Appoints Benjamin Sutton as Global Editor-in-Chief of The Art Newspaper
AMTD Group, AMTD IDEA Group, AMTD Digital Inc., and The Generation Essentials Group have announced the appointment of Benjamin Sutton as the Global Editor-in-Chief of The Art Newspaper. Sutton, who previously served as Editor in Chief for Americas, will now lead the publication's global …
UnitedHealth Group stock holds steady as healthcare sector hits record high
UnitedHealth Group stock is trading below its recent peak despite the S&P 500 healthcare sector reaching a record high, driven by strong investor appetite. The company's diverse operations, including UnitedHealthcare insurance and the Optum services platform, along with its consistent dividend stream, support its …
NetEase Cloud Music Inc. Reports First Half 2026 Financial Results
NetEase Cloud Music Inc. announced its financial results for the first half of 2026, reporting a revenue of RMB4.0 billion, a 3.4% increase year-over-year. The company focused on strengthening its core online music business, diversifying content offerings, enhancing personalized recommendations, and expanding its community …
Sharemaestro market context Trend signal active 52 weeks -5.4%How BigBear.ai’s New Defense Leader on the Board Could Shape BBAI’s Government AI Strategy
BigBear.ai Holdings, Inc. appointed Ret. Lt. Gen. Sean Gainey to its Board of Directors, aiming to leverage his extensive defense technology experience to strengthen government and defense AI markets. While Gainey's expertise supports the company's defense-focused AI strategy, the company still faces challenges including …
NetEase Q2 Earnings Call Highlights
Key Points Interested in NetEase, Inc.? Here are five stocks we like better. NetEase reported solid second-quarter growth: Revenue rose to RMB 30.1 billion, up 7% year over year, while games and related services increased 10% to RMB 25 billion. Overall gross margin improved …
Sharemaestro market context Trend signal active 52 weeks -5.4%Ulta Beauty (ULTA) Earnings Expected to Grow: Should You Buy?
The market expects Ulta Beauty (ULTA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended July 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might …
Sharemaestro market context Price below Trend Line 52 weeks -4.1% · Next-week setup negative 34.1%CELZ Looks 142.9% Overvalued on GF Value™
Creative Medical Technology Holdings Inc (CELZ) is considered 142.9% overvalued based on GuruFocus' GF Value™ metric, trading at $1.19 per share against an estimated fair value of $0.49. Despite the recent completion of its ADAPT clinical trial for CELZ-201, the company exhibits an extremely …
Creative Medical completes enrollment in chronic back pain trial
Creative Medical Technology Holdings Inc. (NASDAQ:CELZ) has completed the enrollment and treatment of all patients in its ADAPT clinical trial for CELZ-201 (Olastrocel), an investigational therapy for chronic lower back pain. The trial, which included an FDA-cleared opioid expansion cohort, is evaluating the safety, …
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
Creative Medical Technology Holdings (NASDAQ: CELZ) announced the completion of enrollment and treatment in its FDA-cleared ADAPT trial for CELZ-201/Olastrocel, including an opioid expansion cohort, aimed at treating chronic lower back pain. The company reported positive interim safety and efficacy data, with significant functional …
DigitalOcean Holdings Drops 9.3% Amid Sector-Wide Selling
DigitalOcean Holdings (DOCN) experienced a 9.3% plunge on Wednesday due to a sector-wide selloff in software infrastructure stocks, closing at $113.56 per share. The decline mirrored similar drops in peers like Twilio, Applied Digital, and Fastly, suggesting a broader market rotation rather than company-specific …
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in RBC Bearings (RBC)
A downtrend has been apparent in RBC Bearings (RBC) lately with too much selling pressure. The stock has declined 12% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement …
Eaton Supports Emergency Readiness and Energy Resilience for 35 California Healthcare Facilities
Eaton has secured multi-million-dollar contracts with BSD Builders, Inc. to equip 35 skilled nursing facilities in California with advanced power management technology. These upgrades will help the facilities comply with state mandates requiring a minimum of 96 hours of onsite power, enhancing reliability and …
Sharemaestro market context Trend signal active 52 weeks +19.5% · Next-week setup negative 34.9%Tenet (THC) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before …
Dhirubhai Deepwater KG2 Bound For India In ONGC Campaign
Transocean Ltd. has secured a two-year contract for its Dhirubhai Deepwater KG2 drillship with ONGC in India, valued at approximately $300 million. The campaign is set to begin in the first quarter of 2027 and includes options that could extend its work in India …
Terreno Realty acquires Washington industrial property for $8M
Terreno Realty Corporation has acquired an industrial property in Redmond, Washington for approximately $8.0 million. The property consists of a 21,000 square foot industrial distribution building on 1.5 acres, adjacent to an existing Terreno property. The company estimates a stabilized cap rate of 5.9% …